PATENT CLAIM ANALYSIS

Application Number: 16175311
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["424", "450000"]

Abstract:
Disclosed are particles for delivering cytokinese, such as IL-12, for the treatment of cancer. The particles comprise cytokines non-covalently bound to liposomes, where the liposomes are coated with polyelectrolytes.

Claim (Index 7):
The particle of  claim 3 , wherein the peptide tag comprises a histidine monomer.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.30769
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15501028', '15433934', '15518665', '15340238', '14358705']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6372786035539542
- 35 USC 102 Novelty (BERT): 0.5140432409217347
- Combined Prediction Score: 0.6249550672907322
- Mean Citation Score: 180.371654
- Max Citation Score: 194.3446
- Similarity Product: 130.64514026914836

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test